Bcl-7B antibody
Principal name
Bcl-7B antibody
Alternative names for Bcl-7B antibody
BCL7B, Hom s 3, B-cell CLL/lymphoma 7 protein family member B
Ncbi ID
9606, NM_001707, NM_001197244, NP_001698, NP_001184173, NP_001184173.1, NP_033875.2
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection))
Background of Bcl-7B antibody
- Kit Component:
- - KN302113G1, Bcl7b gRNA vector 1 in pCas-Guide vector
- KN302113G2, Bcl7b gRNA vector 2 in pCas-Guide vector
- KN302113D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of BCL7B expression in transfected 293T cell line by BCL7B monoclonal antibody (M01), clone 6D2.Lane 1: BCL7B transfected lysate(22 KDa).Lane 2: Non-transfected lysate.
Detection limit for recombinant GST tagged BCL7B is approximately 0.1ng/ml as a capture antibody.
Western Blot analysis of BCL7B expression in transfected 293T cell line (H00009275-T01) by BCL7B MaxPab polyclonal antibody.Lane 1: BCL7B transfected lysate(22.22 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of BCL7B expression in transfected 293T cell line (H00009275-T01) by BCL7B MaxPab polyclonal antibody.Lane 1: BCL7B transfected lysate(22.20 KDa).Lane 2: Non-transfected lysate.
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301696 | Bcl-7B |
||||
| Recombinant protein of human B-cell CLL/lymphoma 7B (BCL7B) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP330990 | Bcl-7B (transcript variant 2) |
||||
| Purified recombinant protein of Homo sapiens B-cell CLL/lymphoma 7B (BCL7B), transcript variant 2. | |||||
 |
Human | > 80 % Preparation: or Add: Recombint proteins was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY419788 | BCL7B overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY433989 | BCL7B overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC230990L1V | Lenti ORF particles, BCL7B (Myc-DDK tagged) - Human B-cell CLL/lymphoma 7B (BCL7B), transcript variant 2 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||